Latest filing published 27 Sept 2012 for Myriad Pharmaceuticals, Inc., €1,257.
Insider track record
No signal scores available.
Andrea Kendell: trading record in brief
Andrea Kendell discloses dealings in Myriad Pharmaceuticals, Inc. to SEC (Form 4). Over a trading history stretching from 2 July 2012 to 25 September 2012, the count stands at 2 filings.
No open-market purchase appears, only 1 sale worth €1,257. The rest of the record consists of 1 share grant.
The latest filing, published on 27 September 2012, reports an open-market sale of €1,257 in Myriad Pharmaceuticals, Inc. Sales are harder to read than purchases, since they often meet personal needs such as tax or diversification. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.
Companies and markets linked to Andrea Kendell
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 693 shares@ US$2.34Common StockSEC:0001181431-12-052192:0
- 20,000 shares0Common StockSEC:0001181431-12-041377:0
2 of 2 declarations
